1
|
Tranos J, Das A, Zhang J, Hafeez S, Arvanitakis GN, Thomson SAJ, Khan S, Pandya N, Kim SG, Wadghiri YZ. Rapid In Vitro Quantification of a Sensitized Gadolinium Chelate via Photoinduced Triplet Harvesting. ACS OMEGA 2023; 8:2907-2914. [PMID: 36713694 PMCID: PMC9878670 DOI: 10.1021/acsomega.2c05040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/07/2022] [Accepted: 11/18/2022] [Indexed: 06/18/2023]
Abstract
Gadolinium (Gd) based contrast agents (GBCAs) are widely used in magnetic resonance imaging (MRI) and are paramount to cancer diagnostics and tumor pharmacokinetic analysis. Accurate quantification of gadolinium concentration is essential to monitoring the biodistribution, clearance, and pharmacodynamics of GBCAs. However, current methods of quantifying gadolinium in blood or plasma (biological media) are both low throughput and clinically unavailable. Here, we have demonstrated the use of a sensitized gadolinium chelate, Gd[DTPA-cs124], as an MRI contrast agent that can be used to measure the concentration of gadolinium via luminescence quantification in biological media following transmetalation with a terbium salt. Gd[DTPA-cs124] was synthesized by conjugating carbostyril-124 (cs124) to diethylenetriaminepentaacetic acid (DTPA) and chelating to gadolinium. We report increases in both stability and relaxivity compared to the clinically approved analog Gd[DTPA] (gadopentetic acid or Magnevist). In vivo MRI experiments were conducted using C57BL6 mice in order to further illustrate the performance of Gd[DTPA-cs124] as an MRI contrast agent in comparison to Magnevist. Our results indicate that similar chemical modification to existing clinically approved GBCA may likewise provide favorable property changes, with the ability to be used in a gadolinium quantification assay. Furthermore, our assay provides a straightforward and high-throughput method of measuring gadolinium in biological media using a standard laboratory plate reader.
Collapse
Affiliation(s)
- James
A. Tranos
- Center
for Biomedical Imaging (CBI), Center for Advanced Imaging Innovation
and Research (CAI2R), Department of Radiology, NYU Grossman School of Medicine, New York, New York 10016, United States
| | - Ayesha Das
- Department
of Radiology, Weill Cornell Medical College, New York, New York 10065, United States
| | - Jin Zhang
- Department
of Radiology, Weill Cornell Medical College, New York, New York 10065, United States
| | - Sonia Hafeez
- Center
for Biomedical Imaging (CBI), Center for Advanced Imaging Innovation
and Research (CAI2R), Department of Radiology, NYU Grossman School of Medicine, New York, New York 10016, United States
| | | | | | - Suleiman Khan
- Center
for Biomedical Imaging (CBI), Center for Advanced Imaging Innovation
and Research (CAI2R), Department of Radiology, NYU Grossman School of Medicine, New York, New York 10016, United States
| | - Neelam Pandya
- Center
for Biomedical Imaging (CBI), Center for Advanced Imaging Innovation
and Research (CAI2R), Department of Radiology, NYU Grossman School of Medicine, New York, New York 10016, United States
| | - Sungheon Gene Kim
- Department
of Radiology, Weill Cornell Medical College, New York, New York 10065, United States
| | - Youssef Z. Wadghiri
- Center
for Biomedical Imaging (CBI), Center for Advanced Imaging Innovation
and Research (CAI2R), Department of Radiology, NYU Grossman School of Medicine, New York, New York 10016, United States
| |
Collapse
|
2
|
Ledwaba M, Masilela N, Nyokong T, Antunes E. Surface modification of silica-coated gadolinium oxide nanoparticles with zinc tetracarboxyphenoxy phthalocyanine for the photodegradation of Orange G. ACTA ACUST UNITED AC 2015. [DOI: 10.1016/j.molcata.2015.03.023] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
|
3
|
Danhier P, Gallez B. Electron paramagnetic resonance: a powerful tool to support magnetic resonance imaging research. CONTRAST MEDIA & MOLECULAR IMAGING 2014; 10:266-81. [PMID: 25362845 DOI: 10.1002/cmmi.1630] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/13/2014] [Accepted: 09/18/2014] [Indexed: 12/31/2022]
Abstract
The purpose of this paper is to describe some of the areas where electron paramagnetic resonance (EPR) has provided unique information to MRI developments. The field of application mainly encompasses the EPR characterization of MRI paramagnetic contrast agents (gadolinium and manganese chelates, nitroxides) and superparamagnetic agents (iron oxide particles). The combined use of MRI and EPR has also been used to qualify or disqualify sources of contrast in MRI. Illustrative examples are presented with attempts to qualify oxygen sensitive contrast (i.e. T1 - and T2 *-based methods), redox status or melanin content in tissues. Other areas are likely to benefit from the combined EPR/MRI approach, namely cell tracking studies. Finally, the combination of EPR and MRI studies on the same models provides invaluable data regarding tissue oxygenation, hemodynamics and energetics. Our description will be illustrative rather than exhaustive to give to the readers a flavour of 'what EPR can do for MRI'.
Collapse
Affiliation(s)
- Pierre Danhier
- Biomedical Magnetic Resonance Research Group, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium
| | - Bernard Gallez
- Biomedical Magnetic Resonance Research Group, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium
| |
Collapse
|